Minerva Neurosciences
NERV
76 hedge funds and large institutions have $95.4M invested in Minerva Neurosciences in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 30 reducing their positions, and 14 closing their positions.
0.17% more ownership
Funds ownership: 8.85% → 9.03% (+0.17%)
5% less funds holding
Funds holding: 80 → 76 (-4)
7% less capital invested
Capital invested by funds: $103M → $95.4M (-$7.4M)
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
38% less call options, than puts
Call options by funds: $552K | Put options by funds: $891K
43% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.94M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.67M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.59M |
| 4 |
FM
Frazier Management
Seattle,
Washington
|
+$1.86M |
| 5 |
Goldman Sachs
New York
|
+$1.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.48M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$924K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$915K |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$708K |
| 5 |
Jane Street
New York
|
-$696K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Squarepoint
New York
| – | -$83K | -2,874 | Closed |
|
|
WS
77
Wedbush Securities
Los Angeles,
California
| – | -$69K | -2,392 | Closed |
|
78
SG Americas Securities
New York
| – | -$64K | -2,232 | Closed |
|
|
EGM
79
Engineers Gate Manager
New York
| – | -$57K | -1,975 | Closed |
|
|
TSS
80
Two Sigma Securities
New York
| – | -$41K | -1,410 | Closed |
|
|
VF
81
Virtu Financial
New York
| – | -$39K | -1,344 | Closed |
|
|
QI
82
QS Investors
New York
| – | -$4K | -125 | Closed |
|
|
APWM
83
Atlas Private Wealth Management
Albany,
New York
| – | -$1K | -50 | Closed |
|
|
PHK
84
Point72 Hong Kong
Hong Kong
| – | -$1K | -42 | Closed |
|
85
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$811 | -30 | -79% |
|
86
Simplex Trading
Chicago,
Illinois
| – | +$268K | +9,926 | New |
|
NERV Hedge Fund Activity: Q3 2020 in Review
76 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q3 2020, worth a combined $95.4M — down 7.2% from $103M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of NERV and 10 opened new positions — a net loss of 4 holders — while 30 trimmed existing stakes and 17 added.
The largest buyer was Vanguard Group, adding an estimated $2.94M. The largest seller was Fidelity Investments, cutting an estimated $3.48M.
- 76 institutional investors held Minerva Neurosciences (NERV) as of Q3 2020, down from 80 in Q2 2020.
- Funds reported $95.4M of Minerva Neurosciences stock for Q3 2020, down 7.2% quarter-over-quarter.
- 10 funds opened new Minerva Neurosciences positions in Q3 2020 and 14 closed out, a net change of -4 holders.
- The largest Minerva Neurosciences buyer in Q3 2020 was Vanguard Group, an estimated $2.94M added.
- The largest Minerva Neurosciences seller in Q3 2020 was Fidelity Investments, an estimated $3.48M sold.
Based on aggregated 13F filings for Q3 2020.